Current Opinion in Pulmonary Medicine

Article	Citations
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis	69
Bronchoscopic treatment of early-stage peripheral lung cancer	41
The persistent problem of persistent air-leaks: approach to management	32
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis	26
Thoracic computed tomography in the progressive fibrotic phenotype	26
Labelling and denominating lung toxicity effects of pesticides	25
Thoracic empyema: aetiology, diagnosis, treatment, and prevention	25
The role of PET in the management of sarcoidosis	25
Home monitoring in asthma: towards digital twins	23
The evolving role of radiological imaging in cystic fibrosis	22
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis	21
Improving care in lung cancer surgery: a review of quality measures and evolving standards	21
Lung microbiome, gut–lung axis and chronic obstructive pulmonary disease	21
Digital outcome measures in pulmonary clinical trials	20
The justification for the progressive fibrotic phenotype	18
Direct oral anticoagulant use in special populations	18
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?	18
The different facets of sickle cell disease-related pulmonary hypertension	18
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?	17
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?	17
Implementation of digital home monitoring and management of respiratory disease	17
Group 2 pulmonary hypertension: from diagnosis to treatment	16
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients	16
Bronchoscopic diagnosis of peripheral lung lesions	16
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease	16

Editorial: A future focus on cystic fibrosis in an era of uncertainty despite opportunity	16
Editorial introductions	15
Editorial introductions	14
Paediatric asthma - all that wheezes is not necessarily asthma - current diagnostic and management strategies	14
Asthma in pregnancy: a review of recent literature	14
Considerations and clinical management of infections in sarcoidosis	14
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes	13
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions	13
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens	13
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant	13
The future of clinical trials in idiopathic pulmonary fibrosis	13
Lung transplant referral considerations for individuals with cystic fibrosis	13
Casting light on the many facets of sarcoidosis	12
Sarcoidosis and frailty: recognizing factors that foster holistic resilience	11
Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice	11
Tobacco treatment in the setting of lung cancer screening	11
Progress for all: addressing disparities in sarcoidosis	11
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing	11
Cystic fibrosis liver disease in the post-modulator era	11
The emerging role of inorganic elements as potential antigens in sarcoidosis	11
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis	11
Acute rejection post lung transplant	11
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease	10
Imaging in peripheral bronchoscopy	10
Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators	10
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease	10
Digital inhalers for asthma management	10
Novel insights in fibrotic pulmonary sarcoidosis	9
What causes cough in pulmonary fibrosis, and how should we treat it?	9
Patterns of progression in non-IPF fibrotic interstitial lung disease	9
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators	9
Home monitoring of coronavirus disease 2019 patients in different phases of disease	9
Editorial: Are we ready for prime time?	9
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease	9
Chronic obstructive pulmonary disease risk assessment tools: is one better than the others?	9
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown	9
Effectiveness and safety of coronavirus disease 2019 vaccines	8
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	8
Editorial: COVID pandemic and Lung cancer: challenges lead to opportunities	8
Severe pulmonary toxicity associated with inhalation of pyrethroid-based domestic insecticides (Bop/Sapolio): a case series and literature review	8
Obstructive lung diseases burden and COVID-19 in developing countries: a perspective	8
Altered pharmacology and toxicology during ageing: implications for lung disease	8
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism	8
Infection control in cystic fibrosis: evolving perspectives and challenges	8
Exhaled breath analysis in interstitial lung disease	8
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future	8
Multidisciplinary care in nonmalignant central airway obstruction	8
Transbronchial biopsy vs. bronchoalveolar lavage in interstitial lung disease	7
The association of preexisting severe asthma with COVID-19 outcomes	7
Epigenetics and aging: relevance for sleep medicine	7

Pediatric interventional bronchoscopy: from early limitations to achievable opportunities	7
Editorial: ‘What is your occupation?’: historical snippets	7
Telerehabilitation in pulmonary diseases	7
Right ventricular assessment in pulmonary hypertension	7
Risk stratification of indeterminate pulmonary nodules	7
Long-term safety, durability of response, cessation and switching of biologics	6
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?	6
Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions	6
Adenotonsillectomy: the good, the bad and the unknown	6
Telehealth and virtual health monitoring in cystic fibrosis	6
Prader–Willi syndrome: an update	6
Military deployment-related respiratory problems: an update	6
Pre-chronic obstructive pulmonary disease: a pathophysiologic process or an opinion term?	6
Shifting gears: the search for group 3 pulmonary hypertension treatment	6
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians	6
Occupational exposures and sarcoidosis: current understanding and knowledge gaps	6
The changing landscape of infections in the lung transplant recipient	6
Approach to the hospitalized patient with pulmonary arterial hypertension	6
Advancements in airway stents: a comprehensive update	6
Bronchoscopic lung volume reduction in emphysema: a review	6
The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease	6
Pulmonary rehabilitation in idiopathic pulmonary fibrosis	6
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections	6
Ergonomics in bronchoscopy	6
Editorial introductions	5
Updates in the diagnosis and management of chronic thromboembolic disease	5
Pulmonary alveolar proteinosis – current and future therapeutical strategies	5
COVID-19 outcomes in people with cystic fibrosis	5
Editorial introductions	5
Pulmonary vascular disease in chronic lung diseases: cause or comorbidity?	5
Artificial intelligence for the optimal management of community-acquired pneumonia	5
Examining the impact of air pollution, climate change, and social determinants of health on asthma and environmental justice	5
Editorial introductions	5
Methamphetamine-associated pulmonary arterial hypertension	5
Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practice	5
Bronchoscopic interventions for chronic bronchitis	4
Rapid eye movement predominant obstructive sleep apnoea: prognostic relevance and clinical approach	4
Recent advances predict a bright future for nebulizers	4
Bacteriophages for bronchiectasis: treatment of the future?	4
Drug-resistant tuberculosis: advances in diagnosis and management	4
Interstitial lung disease following coronavirus disease 2019	4
Editorial introductions	4
Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases	4
Editorial introductions	4
Lobar or sublobar resection of peripheral stage I non-small cell lung cancer	4
Editorial: Endobronchial valve placement for endoscopic lung volume reduction (ELVR): “the start of a new era”	4
What is new in mediastinal staging?	4
Editorial: The role of ageing in pulmonary disease	4
Interrelationships between tuberculosis and chronic obstructive pulmonary disease	4
Clinical trials in pulmonary sarcoidosis; what is needed, what is happening and what is next?	4
Health inequities in the modulator era	4
Cyclic alternating patterns and arousals: what is relevant in obstructive sleep apnea? In Memoriam Mario Giovanni Terzano	4
Whole lung and sequential bronchoscopic lavage for pulmonary alveolar proteinosis	4
Editorial introductions	4
‘Personalized medicine’: phenotyping pediatric obstructive sleep apnea	3
Recent developments in occupational asthma	3
Editorial introductions	3
Perioperative management of Obstructive Sleep Apnoea: Present themes and future directions	3
Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine	3
Indwelling pleural catheters for benign pleural effusions: a concise review	3
The other connective tissue disease-associated interstitial lung diseases: Sjogren's syndrome, mixed connective tissue disease, and systemic lupus erythematosus	3
Obstructive sleep apnea in the patient with atrial fibrillation: current knowledge and remaining uncertainties	3
Management of complicated parapneumonic effusions	3
Endobronchial treatment of severe asthma and severe emphysema with hyperinflation	3
Editorial introduction	3
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide	3
Lung infections due to emerging fungal pathogens	3
Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: an update on pathogenesis and treatment	3
Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulmonary fibrosis (and chronic obstructive pulmonary disease)	3
Anesthetic considerations in interventional pulmonology	3
Applications of artificial intelligence in computed tomography imaging for phenotyping pulmonary hypertension	3
Environmental and occupational exposures in interstitial lung disease	3
Editorial introductions	3
Risk stratification of pulmonary embolism	3
Pulmonary Langerhans cell histiocytosis – an update on pathogenesis and treatment	3
Cryoprobe biopsy versus mechanical biopsies in pulmonary diagnostics	3
Role of biomarkers in lung nodule evaluation	3
Infection control in the bronchoscopy suite: effective reprocessing and disinfection of reusable bronchoscopes	3
Advances in the epidemiology, clinical features, diagnosis, clinical management and prevention of coronavirus disease 2019	2
Asthma guidelines: comparison of the National Heart, Lung, and Blood Institute Expert Panel Report 4 with Global Initiative for Asthma 2021	2

Triple combination cystic fibrosis transmembrane conductance regulator modulator therapy in the real world – opportunities and challenges	2
Glymphatic MRI techniques in sleep and neurodegenerative diseases	2
Telehealth and its implementation in respiratory sleep medicine	2
The controversy over daylight saving time: evidence for and against	2
Predictors and markers of the cardiovascular impact of obstructive sleep apnoea	2
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: advances in patient and lesion selection	2
Percutaneous tracheostomy in the ICU: a review of the literature and recent updates	2
The progressive fibrotic phenotype in current clinical practice	2
The treatment of sarcoidosis: translating the European respiratory guidelines into clinical practice	2
Whole lung lavage: considerations from the anesthesiology perspective	2
COVID-19: vaccines, efficacy and effects on variants	2
Bedside to bench and back again-translational research in interventional pulmonology	2
Editorial: The game is changing in sarcoidosis	2
Vitamin D deficiency in chronic obstructive pulmonary disease	2
Sex differences in sleep and sleep-disordered breathing	2
Editorial introductions	2
SMART - is it practical in the United States?	2
Initiation of home noninvasive ventilation in hypercapnic chronic obstructive pulmonary disease: when, where, and how?	2
Pulmonary adverse events following immune checkpoint inhibitors	2
COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes	2
Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?	2
Progress and challenges in fungal lung disease in cystic fibrosis	2
Lung transplantation: practical and important directions of care	2
Ageing with Interstitial lung disease: preserving health and well being	2
Optimal long-term anticoagulation after acute pulmonary embolism: current state of the art and a look into the near future	2
Epidemiology of advanced cystic fibrosis lung disease in the modulator era	2